|Bid||0.2000 x 0|
|Ask||0.2150 x 0|
|Day's Range||0.2000 - 0.2100|
|52 Week Range||0.1650 - 0.5600|
|Beta (5Y Monthly)||-0.32|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec. 27, 2006|
|1y Target Est||N/A|
Sirona Biochem Corp. (TSXV: SBM) (FSE: ZSB) (OTC: SRBCF) ("Sirona") is pleased to announce the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on November 10, 2021. The total number of shares represented by shareholders present in person and by proxy at the meeting was 33,335,079, representing 14.45% of Sirona's issued and outstanding Common Shares.
Sirona Biochem Corp. (TSXV: SBM) (FSE: ZSB) (US-OTC: SRBCF) ("Sirona") is pleased to inform its shareholders that a video interview with CEO, Dr. Howard Verrico, has been published by Investing News Network https://investingnews.com/ in Vancouver BC, Canada.
Sirona Biochem Corp. (TSXV: SBM) (FSE: ZSB) (OTC: SRBCF) ("Sirona") is pleased to provide the following Q3 update to shareholders.